The $8.3 billion sale of B/E Aerospace was completed Thursday following the European Commission’s regulatory approval of Rockwell Collins’s purchase.
With B/E now part of Rockwell Collins, the Cedar Rapids, Iowa, company has nearly 30,000 employees nationwide and combined annual revenue projected to exceed $8 billion,
The deal was announced after B/E’s board of directors said in May 2014 that it was considering a sale as part of “exploring and evaluating” its strategic alternatives. In June 2014, B/E announced the spin-off what became KLX Inc. into an independent, publicly traded corporation.
The B/E brand has now ended, effective Thursday, and is operating now as Rockwell’s Interior System business.
Werner Lieberherr, B/E’s president and chief executive and the company’s top local officer, has transitioned to chief operating officer of the Interior Systems business.
Rockwell gains with the deal a wide range of cabin interior products for commercial aircraft and business jets, including seating, food and beverage preparation and storage equipment, lighting and oxygen systems, and modular galley and lavatory systems.
Full Content: Journal Now
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas